These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1657494)

  • 21. The determination of oxalate in haemodialysate and plasma: a means to detect and study 'hyperoxaluria' in haemodialysed patients.
    Wolthers BG; Meijer S; Tepper T; Hayer M; Elzinga H
    Clin Sci (Lond); 1986 Jul; 71(1):41-7. PubMed ID: 3709074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 1 primary hyperoxaluria: A case report and focus on bone impairment of systemic oxalosis.
    Pijnenburg L; Caillard S; Boivin G; Rizzo S; Javier RM
    Morphologie; 2018 Mar; 102(336):48-53. PubMed ID: 29102553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
    Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
    Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ; Swee ML; Fillaus JA
    Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined liver kidney transplantation in primary hyperoxaluria type I. Prevention of the recidive of calcium oxalate deposits in the renal graft.
    Lloveras JJ; Durand D; Dupre C; Rischman P; Fourtanier G; Ton That H; Suc JM
    Clin Nephrol; 1992 Sep; 38(3):128-31. PubMed ID: 1395163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children.
    Ellis SR; Hulton SA; McKiernan PJ; de Ville de Goyet J; Kelly DA
    Nephrol Dial Transplant; 2001 Feb; 16(2):348-54. PubMed ID: 11158411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kinetics of oxalate in hemodialysis].
    Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
    Minerva Urol Nefrol; 1991; 43(3):165-9. PubMed ID: 1817340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure.
    Alkhunaizi AM; Chan L
    J Am Soc Nephrol; 1996 Nov; 7(11):2320-6. PubMed ID: 8959621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.
    D'Costa MR; Winkler NS; Milliner DS; Norby SM; Hickson LJ; Lieske JC
    Am J Kidney Dis; 2019 Sep; 74(3):417-420. PubMed ID: 30910370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD.
    Bunchman TE; Swartz RD
    Perit Dial Int; 1994; 14(1):81-4. PubMed ID: 8312423
    [No Abstract]   [Full Text] [Related]  

  • 32. Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease.
    Hueppelshaeuser R; von Unruh GE; Habbig S; Beck BB; Buderus S; Hesse A; Hoppe B
    Pediatr Nephrol; 2012 Jul; 27(7):1103-9. PubMed ID: 22366809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Echocardiographic features in a patient with primary oxalosis.
    Yoshioka J; Park YD; Tanaka Y; Kobayashi Y; Miyajima M; Tani A; Hori M; Shirai D
    Echocardiography; 2001 Oct; 18(7):599-602. PubMed ID: 11737970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.
    Mizusawa Y; Parnham AP; Falk MC; Burke JR; Nicol D; Yamanaka J; Lynch SV; Strong RW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):361-5. PubMed ID: 9361924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Allograft With Calcium Oxalate Deposition: Association with Urinary Tract Infection and Development of Interstitial Fibrosis.
    Özdemir BH; Ayva Ş; Özdemir G; Ok Atılgan A; Akçay E; Özdemir FN; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):126-130. PubMed ID: 29528009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxalate removal by hemodialysis in end-stage renal disease.
    Ramsay AG; Reed RG
    Am J Kidney Dis; 1984 Sep; 4(2):123-7. PubMed ID: 6475942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of oxalate balance in patients on chronic peritoneal dialysis.
    Marangella M; Bagnis C; Bruno M; Petrarulo M; Gabella P; Linari F
    Am J Kidney Dis; 1993 Apr; 21(4):419-26. PubMed ID: 8465823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
    Perinpam M; Enders FT; Mara KC; Vaughan LE; Mehta RA; Voskoboev N; Milliner DS; Lieske JC
    Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
    Hoppe B; Dittlich K; Fehrenbach H; Plum G; Beck BB
    Am J Kidney Dis; 2011 Sep; 58(3):453-5. PubMed ID: 21705122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.